Evidence map›Paper›PMID 40070996›Full record

ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2025

Comparison of the Effect of Weekly Cisplatin Versus Three Weekly Cisplatin in Concurrent Chemoradiotherapy of Head and Neck Cancer: A Pilot Study.

Anushree Chaturvedi, Amit Sehrawat, Trivikrama Rao Mopidevi, K M Parthasarthy, Deni Gupta, Anuj Singh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anushree ChaturvediNational Institute of Medical Science and Research, Jaipur, Rajasthan India.
Amit SehrawatAll India Institute of Medical Sciences, Rishikesh, Uttarakhand India.
Trivikrama Rao MopideviAmerican Oncology Institute, Hisar, Haryana India.
K M ParthasarthyDharamshila Narayana Superspeciality Hospital, New Delhi, India.
Deni GuptaDharamshila Narayana Superspeciality Hospital, New Delhi, India.
Anuj SinghNational Institute of Medical Science and Research, Jaipur, Rajasthan India.ORCID 0000-0001-9607-0588

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with squamous cell carcinoma of the head and neck (HNSCC) often present with advanced locoregional disease. Combined modality treatment with definitive concurrent chemoradiotherapy (CTRT) has become the standard of care for these cancers. We compared the efficacy and toxicity profile of weekly cisplatin regime compared to a three-weekly cisplatin regime in the setting of definitive CTRT for locally advanced HNSCC (LAHNSCC). 51 patients were enrolled in the study between May 2016 and June 2019. In arm A, 25 patients (n = 25) were given three weekly cisplatin at dose of 100 mg/m

Indexed as

Cisplatin in concurrent chemoradiationCisplatin regime in Head and Neck cancerDefinitive chemoradiation in Head and Neck CancerLocally advance head and neck cancerWeekly v/s 3 weekly Cisplatin

Identifiers

PMID40070996
PMCPMC11890838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.